MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
Accelerate Diagnostics Shares 2011-2026 | AXDX
Annual Shares Accelerate Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 82.2 M | 61.7 M | 56 M | 54.5 M | 54.5 M | 54.1 M | 51.3 M | 45 M | 43.6 M | 37.5 M | 12.5 M | 10.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 82.2 M | 10.8 M | 47 M |
Quarterly Shares Accelerate Diagnostics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24.9 M | 23.1 M | 14.6 M | 14.4 M | 11 M | 98.3 M | 9.75 M | 8.7 M | 7.62 M | 67.8 M | 67.6 M | 61.1 M | 61 M | 58.5 M | 57.6 M | 56.6 M | 55.4 M | 54.8 M | 54.7 M | 54.6 M | 54.5 M | 54.3 M | 54.2 M | 54.1 M | 54 M | 55.6 M | 55.7 M | 55.3 M | 53.6 M | 51.9 M | 51.5 M | 51.2 M | 51.2 M | 51.2 M | 51.2 M | 44.7 M | 44.7 M | 44.6 M | 44.6 M | 44.6 K | 43.5 K | 41.9 K | 41.6 M | 39.9 K | 38.9 K | 29.1 K | 11.1 M | 25 M | 11.8 M | 25.3 M | 10.8 M | 11.1 M | 10.8 M | 11.1 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 98.3 M | 29.1 K | 37 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Trinity Biotech plc
TRIB
|
83.6 M | $ 0.65 | -1.84 % | $ 61.9 M |  Irlanda |
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Agilent Technologies
A
|
304 M | $ 115.55 | 1.0 % | $ 35.1 B |  USA |
 |
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
1.33 M | $ 1.67 | -2.34 % | $ 2.22 M | USA |
 |
Castle Biosciences
CSTL
|
27.8 M | $ 24.46 | 3.25 % | $ 679 M | USA |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 21.23 | 5.83 % | $ 1.13 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 84.33 | 1.82 % | $ 5.69 B | USA |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 16.31 | 1.75 % | $ 493 M | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 410.54 | 4.35 % | $ 11.8 B | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 169.8 | 1.23 % | $ 8.42 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Guardant Health
GH
|
125 M | $ 88.91 | 1.18 % | $ 11.1 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
4.42 M | $ 1.98 | -2.37 % | $ 8.76 M | USA |
 |
Illumina
ILMN
|
159 M | $ 127.88 | 1.95 % | $ 20.3 B | USA |
 |
National Research Corporation
NRC
|
22.4 M | $ 17.23 | -0.12 % | $ 386 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
904 M | $ 27.47 | -0.58 % | $ 20 B |  Niderland |
 |
Personalis
PSNL
|
59.3 M | $ 6.1 | 3.39 % | $ 361 M | USA |
 |
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
2.3 M | $ 2.14 | -0.47 % | $ 4.92 M | USA |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 102.17 | -3.92 % | $ 8.43 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 263.8 | -0.43 % | $ 21.9 B | USA |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
Celcuity
CELC
|
46.8 M | $ 121.03 | 6.58 % | $ 5.66 B | USA |
 |
Thermo Fisher Scientific
TMO
|
377 M | $ 469.71 | 0.64 % | $ 177 B | USA |
 |
NeoGenomics
NEO
|
128 M | $ 8.29 | 4.8 % | $ 1.06 B | USA |
 |
Neogen Corporation
NEOG
|
217 M | $ 9.54 | 2.03 % | $ 2.07 B | USA |
 |
Twist Bioscience Corporation
TWST
|
59.8 M | $ 60.94 | 3.55 % | $ 3.64 B | USA |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 4.78 | -0.21 % | $ 443 M | USA |
 |
Natera
NTRA
|
98.4 M | $ 203.75 | 1.3 % | $ 20.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 196.27 | -1.66 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
236 M | - | - | $ 21.2 M | USA |
 |
Organovo Holdings
ONVO
|
1.46 M | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
4.66 M | - | -16.95 % | $ 1.54 M | USA |
 |
Waters Corporation
WAT
|
59.5 M | $ 309.87 | -0.43 % | $ 18.5 B | USA |